{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:59:00Z","timestamp":1793890740288,"version":"4.8.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.diabet.2026.101742","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T15:51:49Z","timestamp":1771084309000},"page":"101742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reassessing the role of GLP-1 receptor agonists in colorectal cancer Care"],"prefix":"10.1016","volume":"52","author":[{"given":"Baodong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2072-444X","authenticated-orcid":false,"given":"Zhiyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2026.101742_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2026.101734","article-title":"Association between glucagon-like peptide-1 receptor agonists and colorectal cancer survival: a population-based cohort study","volume":"52","author":"Dosda","year":"2026","journal-title":"Diab Metab"},{"key":"10.1016\/j.diabet.2026.101742_bib0002","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12874-025-02633-y","article-title":"Causal estimation of time-varying treatments in observational studies: a scoping review of methods, applications, and missing data practices","volume":"25","author":"Rop","year":"2025","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.diabet.2026.101742_bib0003","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/jamainternmed.2025.5792","article-title":"Active comparator new user cohort studies and matching","volume":"186","author":"St\u00fcrmer","year":"2026","journal-title":"JAMA Int Med"},{"key":"10.1016\/j.diabet.2026.101742_bib0004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12874-022-01828-x","article-title":"Predicting the risk of a clinical event using longitudinal data: the generalized landmark analysis","volume":"23","author":"Yao","year":"2023","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.diabet.2026.101742_bib0005","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jama.2025.13350","article-title":"Transparent reporting of observational studies emulating a target trial-the TARGET Statement","volume":"334","author":"Cashin","year":"2025","journal-title":"JAMA"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363626000212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363626000212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:18:36Z","timestamp":1777288716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363626000212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1262363626000212"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2026.101742","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reassessing the role of GLP-1 receptor agonists in colorectal cancer Care","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2026.101742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101742"}}